The ratio of cortisol/DHEA in treatment resistant depression

Psychoneuroendocrinology

Volumn 34, Issue 1, 2009, Pages 19-26

  Markopoulou, Kalypso ^a,b   Papadopoulos, Andrew ^a,b   Juruena, Mario F ^a,b   Poon, Lucia ^b   Pariante, Carmine M ^a   Cleare, Anthony J ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cortisol; DHEA; Glucocorticoids; HPA axis; Hypercortisolaemia; Treatment resistant depression

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BUSPIRONE; HYDROCORTISONE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PRASTERONE; THYROID HORMONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR DEPRESSION; MALE; PRASTERONE BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; BIOMARKERS, PHARMACOLOGICAL; DEHYDROEPIANDROSTERONE; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 57649200774     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.08.004     Document Type: Article

References (44)

1. Alhaj H.A., Massey A.E., and McAllister-Williams R.H. Effects of DHEA administration on episodic memory, cortisol and mood in healthy young men: a double-blind, placebo-controlled study. Psychopharmacology 188 (2006) 541-551
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth edition (1995), American Psychiatric Association, Washington, DC
3. Barrett-Connor E., and Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 81 1 (1996) 59-64
4. Bauer M.E., Papadopoulos A., Poon L., Perks P., Lightman S.L., Checkley S., and Shanks N. Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression. Psychiat. Res. 113 (2002) 1-15
5. Browne E.S., Wright B.E., Porter J.R., et al. Dehydroepiandrosterone: antiglucocorticoid action in mice. Am. J. Med. Sci. 303 6 (1992) 366-371
6. Cardounel A., Regelson W., and Kalimi M. Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc. Soc. Exp. Biol. Med. 222 2 (1999) 145-149
7. Cevik R., Gur A., Acar S., Nas K., and Sarac A.J. Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones. BMC. Musculoskelet. Disord. 5 (2004) 47
8. Dubrovsky B. Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol. Biochem. Behav. 84 4 (2006) 644-655
9. Feldman H.A., Johannes C.B., Araujo A.B., Mohr B.A., Longcope C., and McKinlay J.B. Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am. J. Epidemiol. 153 1 (2001) 79-89
10. Gagliardi, L., Torpy, D.J., 2008. Chronic Fatigue Syndrome in http://www.endotext.org; Section: Adrenal Physiology and Disease. Section editor: George Chrousos.
11. Gallagher P., Malik N., and Newham J. Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst. Rev. (2008)
12. Ghizzoni, L., Mastorakos, G., 2008. Adrenal Androgens in http://www.endotext.org; Section: Adrenal Physiology and Disease. Section editor: George Chrousos.
13. Goodyer I.M., Herbert J., Altham P.M., Pearson J., Secher S.M., and Shiers H.M. Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med. 26 2 (1996) 245-256
14. Goodyer I.M., Herbert J., Tamplin A., and Altham P.M. Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br. J. Psychiatry 177 (2000) 499-504
15. Goodyer I.M., Park R.J., and Herbert J. Psychosocial and endocrine features of chronic first-episode major depression in 8-16 year olds. Biol. Psychiatry 50 5 (2001) 351-357
16. Groschl M., Rauh M., Schmid P., and Dorr H.G. Relationship between salivary progesterone, 17-hydroxyprogesterone, and cortisol levels throughout the normal menstrual cycle of healthy postmenarcheal girls. Fertil. Steril. 76 (2001) 615-617
17. Guazzo E.P., Kirkpatrick P.J., and Goodyer I.M. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab. 81 11 (1996) 3951-3960
18. Juruena M.F., Cleare A.J., Bauer M.E., and Pariante C.M. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatr. 15 6 (2003) 354-367
19. IBL, Immuno-Biological Laboratories, Hamburg, 2007. Saliva Diagnostics. Pamphlet http://www.ibl-hamburg.com.
20. Kahl K.G., Bens S., Ziegler K., Rudolf S., Dibbelt L., Kordon A., and Schweiger U. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biol. Psychiatry 59 (2006) 667-671
21. Kalimi M., Shafagoj Y., Loria R., Padgett D., and Regelson W. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol. Cell Biochem. 131 (1994) 99-104
22. Karishma K.K., and Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16 (2002) 445-453
23. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., and Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 1852-1857
24. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., and Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 61 (1999) 154-162
25. Kroboth P.D., Amico J.A., Stone R.A., Folan M., Frye R.F., Kroboth F.J., Bigos K.L., Fabian T.J., Linares A.M., Pollock B.G., and Hakala C. Influence of DHEA administration on 24-h cortisol concentrations. J. Clin. Psychopharmacol. 23 (2003) 96-99
26. Maccario M., Mazza E., and Ramunni J. Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin. Endocrinol. (Oxford) 50 5 (1999) 595-600
27. McCormick C.M., and Teillon S.M. Menstrual cycle variation in spatial ability: relation to salivary cortisol levels. Horm. Behav. 39 (2001) 29-38
28. Michael A., Jenaway A., Paykel E.S., and Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol. Psychiatry 48 10 (2000) 989-995
29. Nemeroff C.B. Prevalence and management of treatment-resistant depression. J. Clin. Psychiatry 68 Suppl. 8 (2007) 17-25
30. Ohashi M., Fujio N., and Kato K. Aging is without effect on the pituitary-adrenal axis in men. Gerontology 32 6 (1986) 335-339
31. Parry B.L., Javeed S., Laughlin G.A., Hauger R., and Clopton P. Cortisol circadian rhythms during the menstrual cycle and with sleep deprivation in premenstrual dysphoric disorder and normal control subjects. Biol. Psychiatry 48 (2000) 920-931
32. Reus V.I., Wolkowitz O.M., and Frederick S. Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology 22 Suppl. (1997) 121-124
33. Roca C.A., Schmidt P.J., Altemus M., Deuster P., Danaceau M.A., Putnam K., and Rubinow D.R. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J. Clin. Endocrinol. Metab. 88 (2003) 3057-3063
34. Rosenfeld R.S., Rosenberg B.J., Fukushima D.K., et al. 24-H secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J. Clin. Endocrinol. Metab. 40 5 (1975) 850-855
35. Sackeim H.A. The definition and meaning of treatment-resistant depression. J. Clin. Psychiatry 62 Suppl. 16 (2001) 10-17
36. Svec F., and Shawar A.L. The acute effect of a noontime meal on the serum levels of cortisol and DHEA in lean and obese women. Psychoneuroendocrinology 22 Suppl. 1 (1997) 115-119
37. Task force on laboratory tests in psychiatry: the dexamethasone suppression test: an overview of its current status in psychiatry, 1987. Am. J. Psychiatry. 144(10), 1253-1262.
38. Taylor D., Paton C., and Kerwin R.W. The South London and Maudsley NHS Trust 2005 Prescribing Guidelines. eighth edition (2005), Martin Dunitz, London
39. Thase M.E., and Rush A.J. In: Bloom F.E., and Kupfer D.J. (Eds). Treatment-Resistant Depression, in Psychopharmacology. The Fourth Generation of Progress (1995), Raven Press, New York 1081-1098
40. Ukkola O., Gagnon J., and Rankinen T. Age, body mass index, race and other determinants of steroid hormone variability: the heritage family study. Eur. J. Endocrinol. 145 1 (2001) 1-9
41. Van B.F., and Verkes R.J. Neurosteroids in depression: a review. Psychopharmacology (Berl.) 165 2 (2003) 97-110
42. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., and Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry 156 4 (1999) 646-649
43. Wolkowitz O.M., Reus V.I., Roberts E., Manfredi F., Chan T., Raum W.J., Ormiston S., Johnson R., Canick J., Brizendine L., and Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol. Psychiatry 41 (1997) 311-318
44. Young A.H., Gallagher P., and Porter R.J. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am. J. Psychiatry 159 7 (2002) 1237-1239